[HTML][HTML] Diagnosis and management of 5-fluorouracil (5-FU)-induced acute leukoencephalopathy: Lessons learnt from a single-Centre case series
N Jose, A Joel, RJ Selvakumar, J Ramireddy… - Journal of the Egyptian …, 2022 - Springer
Background The administration of 5-fluorouracil (5FU) in the treatment of gastrointestinal
(GI) malignancies is associated with common side effects such as mucositis, diarrhoea, and …
(GI) malignancies is associated with common side effects such as mucositis, diarrhoea, and …
5-FU-induced leukoencephalopathy with reversible lesion of splenium of corpus callosum in a patient with colorectal cancer
G Acharya, MTC Carreras, TW Rice - Case Reports, 2017 - casereports.bmj.com
5-Fluorouracil (5-FU), a commonly used antimetabolite and antineoplastic agent, has been
approved for treatment of various cancers. Neurotoxicities are considered extremely rare …
approved for treatment of various cancers. Neurotoxicities are considered extremely rare …
[HTML][HTML] MRI characteristics of chemotherapy-related central neurotoxicity: a pictorial review
MFG Isaac, R Alkhatib, CL Ho - Insights into Imaging, 2024 - Springer
The relentless advancement of chemotherapeutic agents has enhanced survival rates
among cancer patients. However, this success comes with an increased prevalence of …
among cancer patients. However, this success comes with an increased prevalence of …
[HTML][HTML] A unique presentation of 5-fluorouracil (5-FU) induced cerebral encephalopathy
SS Naik, I Vanidassane, E Dhamija… - Indian Journal of …, 2020 - thieme-connect.com
5-Fluorouracil (5-FU), a commonly used antimetabolite and antineoplastic agent, has been
approved for the treatment of various cancers. It is associated with systemic side-effects such …
approved for the treatment of various cancers. It is associated with systemic side-effects such …
[PDF][PDF] 5-Fluorouracil Neurotoxicity in a Patient With Normal Dihydropyrimidine Dehydrogenase Activity
U Natarajan, A Onyechi, J Ohemeng-Dapaah - Cureus, 2023 - cureus.com
Introduction 5-fluorouracil (5-FU) is an antineoplastic agent used in the treatment of various
malignancies such as colorectal, breast, stomach, and pancreatic cancer. When 5-FU is …
malignancies such as colorectal, breast, stomach, and pancreatic cancer. When 5-FU is …
An imaging-based review of systemic therapies and associated toxicities in metastatic pancreatic cancer as per the 2018 ASCO guidelines: what every radiologist …
DA Smith, B Somarouthu, NH Ramaiya - Abdominal Radiology, 2019 - Springer
Objective To provide an overview of what radiologists should know about systemic agents
utilized in the modern treatment of metastatic pancreatic cancer and their associated …
utilized in the modern treatment of metastatic pancreatic cancer and their associated …
[HTML][HTML] 5-Fluorouracil related encephalopathy and status epilepticus: A case report
AAM Banibakr, M Imran, R Abu-Omr… - Journal of Radiation …, 2023 - journals.lww.com
Fluoroacil (5-FU)-based chemotherapy has been widely used in the treatment of different
cancer in adjuvant and metastatic settings. The common side effects related to 5-FU are …
cancer in adjuvant and metastatic settings. The common side effects related to 5-FU are …
Encephalopathy: case report
WW Lee - Reactions, 2012 - Springer
The man started receiving chemotherapy with IV fluorouracil 410mg daily, for gastric cancer.
He experienced nausea and vomiting, and on day 4 of his first cycle of treatment he became …
He experienced nausea and vomiting, and on day 4 of his first cycle of treatment he became …